1380329-76-9Relevant academic research and scientific papers
USE OF A PHOSPHODIESTERASE 10 INHIBITOR FOR THE TREATMENT OF TOURETTE SYNDROME
-
Paragraph 00107, (2021/12/31)
Provided herein are methods of treating Tourette Syndrome in a subject in need thereof by administering to the subject compositions comprising a PDE10 inhibitor of Formula (I). Also disclosed are crystalline solid forms of the compound of Formula (I) and
TRIAZOLOPYRIDINE COMPOUNDS
-
Page/Page column 15, (2012/06/16)
The invention is concerned with triazolopyridine compounds of formula (I) wherein R1, R2, R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These
TRIAZOLOPYRIDINE COMPOUNDS
-
Page/Page column 45, (2012/06/30)
The invention is concerned with triazolopyridine compounds of formula (I), wherein R1, R2 , R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. The
